Immuron (IMRN) Share-based Compensation (2015 - 2022)
Immuron (IMRN) posted Share-based Compensation of -$353939.0 for Q2 2022, down 82432.99% on a QoQ basis from -$428.85 in Q4 2021, and up 78.28% year-over-year from -$198531.4 in Q2 2021.
Powered by 
Analysis
Immuron (IMRN) Share-based Compensation (2015 - 2022) Analysis & Trends
Immuron has reported Share-based Compensation for 7 years, with the latest figure at -$353939.0 in Q2 2022.
- On a quarterly basis, Share-based Compensation rose 78.28% year-over-year to -$353939.0 in Q2 2022; TTM through Jun 2022 was -$2.0 million, a 104.91% decrease from a year earlier, with the FY2025 full-year figure at -$229194.7, down 589.77% from the prior year.
- Share-based Compensation was -$353939.0 for Q2 2022 at Immuron, down from -$428.85 in the prior quarter.
- The five-year high for Share-based Compensation was $6070.0 in Q4 2019, with the low at -$1.6 million in Q2 2021.
- Average Share-based Compensation over 4 years is -$398642.2, with a median of -$15466.7 recorded in 2020.
- The sharpest annual moves came in 2020 and 2021: Share-based Compensation slumped 354.81% in 2020, then surged 97.23% in 2021.
- Over 4 years, Share-based Compensation stood at $6070.0 in 2019, then plunged by 354.81% to -$15466.7 in 2020, then soared by 97.23% to -$428.85 in 2021, then plunged by 82432.99% to -$353939.0 in 2022.
- The last three Share-based Compensation figures came in at -$353939.0 (Q2 2022), -$428.85 (Q4 2021), and -$1.6 million (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 247.00 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 231.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 108.10 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 243.00 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 120.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 77.40 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 83.34 Mn |
| 10 | Immuron | 7.14 Mn | -1.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -353,938.98 |
| Dec 31, 2021 | -428.85 |
| Jun 30, 2021 | -1.63 Mn |
| Dec 31, 2020 | -15,466.67 |
| Dec 31, 2019 | 6,070.00 |
| Jun 30, 2017 | 42.35 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Jun 30, 2015 | 3.37 Mn |
API Access
Immuron Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();